XML 33 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights
As of June 30, 2024 and December 31, 2023, we had the following outstanding Warrants:
As of June 30, 2024
 As of
December 31, 2023
Number of Underlying SharesExercise PriceExpiration
June 2022 Warrants384,615384,615$9.10December 16, 2026
December 2021 Warrants182,630182,630$24.64June 7, 2027
January 2020 Investor Warrants26,81926,819$23.59January 13, 2025
January 2020 Placement Agent Warrants5,9545,954$34.96January 13, 2025
600,018600,018
Summary of Stock-based Compensation Expense
The following table summarizes stock-based compensation expense and the impact it had on operations for the periods presented (in thousands):
Three months ended
June 30,
Six months ended
June 30,
2024202320242023
Cost of sales$— $$— $
Product development— — 
Selling, general, and administrative— 19 41 
Total stock-based compensation$— $23 $$49 
Summary of Option Activity A summary of option activity under all plans for the six months ended June 30, 2024 is presented as follows:
Number of
Options
Weighted
Average
Exercise
Price Per
Share
Weighted
Average
Remaining
Contractual
Life (in years)
Balance at December 31, 202330,575 $5.60 
Granted— — 
Canceled/forfeited— — 
Expired(9)53.33 
Balance at June 30, 202430,566 $5.58 8.2
Vested and expected to vest at June 30, 202427,170 $5.70 8.2
Exercisable at June 30, 202413,149 $6.57 8.0